Our MSc in Cancer Biology and Radiotherapy Physics is ideal if you wish to pursue a career in cancer research and/or cancer therapy involving ionising radiation.
With around 40% of all cancer cure cases involving radiotherapy and the UK soon to have a proton therapy service, the need for multidisciplinary scientists in this field has never been greater.
We aim to develop multidisciplinary scientists to create the necessary skill base that will drive radiotherapy forward in the UK.
This course will enable you to train as a multidisciplinary scientist in this area by covering a variety of subjects in content that is delivered by staff with a range of expertise, including physicists, biologists, engineers, clinicians and oncologists.
Our collaboration with The Christie will allow you to undertake unique research projects in its radiotherapy facilities that cannot be carried out anywhere else in the UK or most of Europe.
This course aims to help you develop:
You will be taught by academics from the University and clinical scientists at The Christie, meaning both fundamental science and its clinical application will be covered equally.
Units are delivered in one-week blocks with a mix of face-to-face content delivery and hands-on practical sessions.
There will be a number of assessed and non-assessed activities to develop your key skills and expand your knowledge base.
There is an also online pre-course element, which will be the beginning of your multidisciplinary scientific journey.
After the taught units, there is an supervised research project that will put into practice the key skills and knowledge acquired in the taught component.
The taught units will be assessed through multiple choice exams and practical assessments.
The research project will be assessed through the submission of a short report and oral presentation.
The taught component, which includes the five core and three optional units, will amount to 120 credits of the 180 credits required for an MSc qualification.
The remaining 60 credits will be obtained through a supervised research project.
Much of the course content is delivered through a collaboration with The Christie .
Our collaboration with The Christie means you will have access to an MRI image guided radiotherapy linear accelerator and a proton therapy centre incorporating a dedicated research room for your research project.
You will also be able to access a range of library and IT facilities throughout the University.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service .
Individual taught units from this MSc can be offered to industry and healthcare professionals as part of a career and professional development programme. Please contact us for further information.
This course will help you gain the knowledge and skills to become a leading healthcare scientist in the public or private sector.
It may also be of interest if you are a healthcare worker in the field of radiotherapy who wishes to advance your career.
The master's qualification gained could act as a stepping stone to further academic qualifications or careers involving medical science research.
This MRes Cancer Biology course will give you advanced knowledge of cellular systems. You will learn about the pathogenesis of cancer, cardiovascular disease, diabetes and kidney fibrosis, along with an exploration of current approaches to cancer gene therapy and immunotherapy.
Visit us on campus throughout the year, find and register for our next open event on http://www.ntu.ac.uk/pgevents.
Do you have a clear and specific interest in cancer, stem cells or developmental biology? Our Master’s programme Cancer, Stem Cells and Developmental Biology combines research in three areas: oncology, molecular developmental biology and genetics. The focus is on molecular and cellular aspects of development and disease, utilising different model systems (mice, zebrafish, C. elegans, organoids and cell lines). The programme will guide you through the mysteries of embryonic growth, stem cells, signalling, gene regulation, evolution, and development as they relate to health and disease.
Given that fundamental developmental processes are so often impacted by disease, an understanding of these processes is vital to the better understanding of disease treatment and prevention. Adult physiology is regulated by developmental genes and mechanisms which, if deregulated, may result in pathological conditions. If you have a specific interest in cancer, stem cells or developmental biology, this Master’s programme is the right choice for you. Cancer, Stem Cells and Developmental Biology offers you international, high ranked research training and education that builds on novel methodology in genomics, proteomics, metabolomics and bioinformatics technology applied to biomedical and developmental systems and processes.
In the Cancer, Stem Cells and Developmental Biology programme you will learn to focus on understanding processes underlying cancer and developmental biology using techniques and applications of post-genomic research, including microarray analysis, next generation sequencing, proteomics, metabolomics and advanced microscopy techniques. You explore research questions concerning embryonic growth, stem cells, signaling pathways, gene regulation, evolution and development in relation to health and disease using various model systems. As a Master’s student you will take theory courses and seminars, as well as master classes led by renowned specialists in the field. The courses are interactive, and challenge you to further improve your writing and presenting skills.
Compared to most other Master’s programmes in cancer and stem cell biology in the Netherlands, in Utrecht we offer:
As a MSc graduate trained in both fundamental and disease-oriented aspects of biomedical genetics you are in great demand. You’ll be prepared for PhD study in one of the participating or associated groups. Alternatively, leaving after obtaining your MSc degree you will profit from a solid education in molecular genetics, in addition to your specialised knowledge of developmental biology. You’ll find your way to biotechnology, the pharmaceutical industry or education.
This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Our programme takes a 'bench to bedside' approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer research.
This 13 week core course aims to:
One week of practical training is provided at the start of the course. This course is assessed through a lab notebook, group assessment, critical essay and an exam that focuses on data analysis and interpretation.
In the second semester, you can choose from a range of 3 week optional courses, before taking the core course “Designing a Research Project”.
In this 14 week core course you will:
Note: students must have a minimum of grade C in semesters 1 and 2 in order to proceed to the research project.
The knowledge and transferable skills developed in this programme will be suitable for those contemplating a PhD or further medical studies, those wishing to work in the health services sector, and those interested in working in the life sciences, biotechnology or pharmaceutical industries, including contract research organisations (CROs). This programme is designed for students with undergraduate degrees in the life sciences, scientists working in the pharmaceutical and biotechnology industries, and clinicians and other healthcare professionals.
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Further information on modules and degree structure is available on the department website: Cancer MSc
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.